🇪🇺 Bimatoprost 0.03% sterile solution in European Union

EMA authorised Bimatoprost 0.03% sterile solution on 8 March 2002

Marketing authorisation

EMA — authorised 8 March 2002

  • Application: EMEA/H/C/000391
  • Marketing authorisation holder: AbbVie Deutschland GmbH & Co. KG
  • Local brand name: Lumigan
  • Indication: Reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension (as monotherapy or as adjunctive therapy to beta-blockers).
  • Status: approved

Read official source →

Other Ophthalmology approved in European Union

Frequently asked questions

Is Bimatoprost 0.03% sterile solution approved in European Union?

Yes. EMA authorised it on 8 March 2002.

Who is the marketing authorisation holder for Bimatoprost 0.03% sterile solution in European Union?

AbbVie Deutschland GmbH & Co. KG holds the EU marketing authorisation.